Skip Navigation

Cardiovascular Research 2001 49(4):851-862; doi:10.1016/S0008-6363(00)00312-6
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Axel, D. I
Right arrow Articles by Karsch, K. R
Right arrow Search for Related Content
PubMed
Right arrow Articles by Axel, D. I
Right arrow Articles by Karsch, K. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells

Dorothea I Axela,*, Anatol Friggea, Jasmin Dittmanna, Heike Rungea, Ioakim Spyridopoulosa, Reimer Riessena, Richard Viebahnb and Karl R Karschc

aMedical Clinic III, Department of Cardiology, University of Tübingen, Otfried-Müller St. 10, D-72076 Tübingen, Germany
bDepartment of Surgery, University of Tübingen, Tübingen, Germany
cBristol Heart Institute, University of Bristol, Bristol, UK

* Corresponding author. Tel.: +49-7071-298-7338; fax: +49-7071-295-749 daaxel{at}med.uni-tuebingen.de

Objective: The vitamin-A derivative all-trans retinoic acid (atRA) is a potent regulator of cell growth, differentiation, and matrix formation of various cell types and plays an important role in embryogenesis. However, sparse data are available about its effects on human vessel diseases. Thus, we studied the effects of atRA on human arterial smooth muscle cell (haSMC) and endothelial cell (haEC) proliferation, migration, differentiation and extracellular matrix (ECM) turnover in mono- and transfilter cocultures. Methods: Effects of atRA on human arterial cells in monocultures were determined using cell counting assays, BrdU-ELISA and MTT-tests. In transfilter cocultures haSMC-growth was studied under the stimulatory effect of proliferating haEC. Using Northern blot analysis, effects of atRA on mRNA expression of ECM-proteins were examined while protein expression and activity of matrix metalloproteinases were determined by Western blotting and zymography. Results: atRA caused a dose dependent inhibition of haSMC-growth in monocultures (IC50 at 0.022 µM) whereas haEC-growth was inhibited less potently (IC50 at 97 µM). In addition, proliferation and migration of haSMC through a porous membrane were inhibited dose dependently by micromolar atRA-doses after non-stop and single dose application of atRA on the endothelial side of the complex transfilter coculture system. Immunostainings and Northern blotting demonstrated an enhanced {alpha}-smooth muscle actin and heavy chain myosin expression in haSMC after atRA-treatment. Whereas mRNA-expression of the glycoproteins thrombospondin-1 and fibronectin were decreased, collagen-1 mRNA expression was even slightly stimulated. Transcription of biglycan and TGF-β1 were not influenced in a specific manner. Finally, protein expression and activity of the matrix metalloproteinases MMP-2 and MMP-9 were inhibited significantly by atRA. Conclusions: atRA was found to be a potent inhibitor of both haSMC-proliferation and -migration, even in coculture with haEC releasing growth factors. In addition, redifferentiation, ECM synthesis and ECM degradation were regulated by atRA which also influence haSMC migration and intima formation. Thus, atRA-treatment seems to be a promising strategy for the inhibition of processes involved both in atherosclerosis and restenosis.

KEYWORDS Cell culture/isolation; Cell communication; Extracellular matrix; Smooth muscle; Restenosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1542 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. Kota, M. Osborne-Pellegrin, H. Schulz, J. Behmoaras, M. Coutard, M. Gong, and N. Hubner
Quantitative genetic basis of arterial phenotypes in the Brown Norway rat
Physiol Genomics, June 19, 2007; 30(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. M. Day, Y. H. Lee, A.-M. Park, and Y. J. Suzuki
Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chen, J. W. Streb, K. M. Maltby, C. M. Kitchen, and J. M. Miano
Cloning of a Novel Retinoid-inducible Serine Carboxypeptidase from Vascular Smooth Muscle Cells
J. Biol. Chem., August 31, 2001; 276(36): 34175 - 34181.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.